JP Patent

JP5670912B2 — ｐ３８ＭＡＰキナーゼ阻害剤

Assigned to レスピバート・リミテツド · Expires 2015-02-18 · 11y expired

What this patent protects

Patent listed against Hernexeos.

Drugs covered by this patent

Hernexeos (ZONGERTINIB) · Boehringer Ingelheim

Patent Metadata

Patent number: JP5670912B2
Jurisdiction: JP
Classification: —
Expires: 2015-02-18
Drug substance claim: No
Drug product claim: No
Assignee: レスピバート・リミテツド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.